Updated Meta-analysis Assessing GLP-1 Agonists for Parkinson’s Disease
Objective: Evaluate the efficacy and safety of Glucagon-like peptide-1 (GLP-1) agonists on Parkinson’s disease (PD). Background: The idea of repositioning drugs used to treat PD…The sphingolipid Lyso-Gb3, a biomarker for the lysosomal storage disorder Fabry Disease, is significantly elevated in blood from patients with Parkinson’s Disease
Objective: To better understand lysosomal dysfunction in Parkinson’s Disease. Background: Lysosomal dysfunction and α-synuclein accumulation play central roles in Parkinson’s Disease. They are interconnected by…Neurocognitive Functioning and Neurobehavioral Alterations in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia by Deep Brain Stimulation. Descriptive Study of the ESDEPARK Scale.
Objective: To identify the clinical correlation between neurocognitive functioning and depressive symptomatology in patients with IPDWD, assessed by a new scale (ESDEPARK) that measures depression…Development of a non-contact monitoring technology for the motor symptoms of Parkinson’s disease using Wi-Fi sensing
Objective: This study aims to develop a non-contact monitoring system using Wi-Fi waves, a widely available household technology, to objectively assess motor symptoms in Parkinson's…Swallowing sound index analysis using electronic stethoscope and artificial intelligence for patients with Parkinson’s disease
Objective: We investigated the swallowing sound index analyzed using an electronic stethoscope with artificial intelligence (AI) corresponds to the severity of Parkinson’s disease.(PD). Background: Several…Gender-Based Differences in Parkinson’s Disease Hospitalization: A Nationwide and Single Center Study
Objective: To analyze hospital admission patterns among patients with Parkinson’s Disease (PD), comparing demographic characteristics, reasons for admission, length of stay, and discharge disposition between…Prevalence and Management of Depression Among Parkinson’s Patient’s in an Outpatient Clinic Setting
Objective: To evaluate the prevalence of depression among Parkinson’s Disease (PD) patients attending an outpatient clinic and review current management to improve diagnosis and treatment…Frequency of Overweight and Obesity in a Cohort of Parkinson’s Disease Patients
Objective: To evaluate the frequency of overweight and obesity in a cohort of patients with Parkinson’s Disease Background: The relationship of overweight and obesity in…Impact of Genetically Defined Ancestry on Progression of Idiopathic Parkinson’s Disease.
Objective: To assess the impact of genetically defined ancestry on progression of idiopathic Parkinson's Disease and evaluate the contribution of known genetic variation on any…Facilitators and Barriers to Exercise Program Implementation in Parkinson’s Disease Rehabilitation: A Comprehensive Review Using the Consolidated Framework for Implementation Research
Objective: To systematically identify and evaluate the facilitators and barriers influencing the implementation of exercise programs in Parkinson’s disease (PD) rehabilitation using the Consolidated Framework…
- « Previous Page
- 1
- …
- 164
- 165
- 166
- 167
- 168
- …
- 1734
- Next Page »